×

CellRapeutics™ CD56+ NK Cells from Human Immunodeficiency Virus HIV Donor (XS-0426-XU296)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product consists of CD56+ NK cells isolated from HIV-positive donors, providing a specialized tool for studying the innate response to chronic viral infection. The population often exhibits phenotypic shifts. These cells are essential for research into Antibody-Dependent Cellular Cytotoxicity and the development of strategies to enhance NK-mediated clearance of the viral reservoir.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ CD56+ NK Cells from Human Immunodeficiency Virus HIV Donor
  • Cat. No.
  • XS-0426-XU296
  • Donor Age
  • Young Adult, Middle-Aged
  • Donor Health
  • NK cells exhibit signatures of chronic viral pressure and potential functional exhaustion. The population is marked by shifts in CD56 and CD56 subset ratios and characteristic alterations in KIR expression diversity.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Acid Citrate Dextrose, selected to stabilize NK cell functional exhaustion markers and ensure maximal recovery of effector cells from immunodeficient peripheral blood environments.
  • Additional Donor Information
  • Each lot features CD56+ NK cells from HIV-positive donors. Profiles include viral load and ART status, supporting research into NK cell exhaustion and their potential in "shock and kill" therapeutic strategies.
  • Clinical Profile
  • Current viral load, CD4+ T-cell count history, duration of HIV infection, and history of Antiretroviral Therapy.

Additional Information

  • Medication History
  • Available upon request. Records of ART history, viral load status, and history of treatments affecting NK cell exhaustion markers and ADCC capacity.
  • Formulation
  • Cryopreserved in specialized freezing medium
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch undergoes rigorous testing for purity, viability, and microbial contamination.
  • Storage
  • Maintain long-term storage in liquid nitrogen vapor phase (below -150°C), avoid temperature fluctuations above -135°C to preserve NK cell lytic activity.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Perform rapid thawing at 37°C and implement slow, dropwise dilution with pre-warmed media to minimize osmotic stress and ensure optimal cell recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 5E6 cells/vial, 1E7 cells/vial
  • Keywords
  • CellRapeutics™ CD56+ NK Cells from Human Immunodeficiency Virus HIV Donor, CD56+ NK Cells, Human Immunodeficiency Virus HIV

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ CD56+ NK Cells from Human Immunodeficiency Virus HIV Donor (XS-0426-XU296). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.